MASTER MIND FINNASSET

Saturday, January 03, 2015

ICICI Prudential Capital Protection Oriented Fund – Series VII – 1284 Days Plan E Floats On

NFO period is from 01 January to 15 January 2015

ICICI Prudential Mutual Fund has launched a new fund named as ICICI Prudential Capital Protection Oriented Fund VII – Plan E, a close ended capital protection oriented scheme.

The tenure of the scheme is 1284 days. The new fund offer (NFO) price for the scheme is Rs 10 per unit. The new issue will be open for subscription from 01 January and will close on 15 January 2015.

The investment objective of the scheme is to seek to protect capital by investing a portion of the portfolio in highest rated debt securities and money market instruments and also provide capital appreciation by investing the balance in equity and equity related securities.

The securities would mature on or before the maturity of the plan under the scheme.

The scheme offers regular plan – cumulative option, direct plan – dividend option, regular plan – cumulative option and regular plan – dividend option.

The scheme would allocate 70%-100% of assets in debt securities & money market instruments with low to medium risk profile and invest upto 30% of assets in equity and equity related securities with medium to high risk profile.

The minimum application amount is Rs 5000 and in multiples of Rs 10 thereafter.

The fund seeks to collect a minimum subscription (minimum target) amount of Rs 20 crore under the scheme during the NFO period.

The scheme is proposed to be listed on NSE.

Entry and exit load charge will be not applicable.

Benchmark Index for the scheme is CRISIL MIP Blended Index.

The fund managers of the scheme are Vinay Sharma (equity portion), Aditya Pagaria & Rahul Goswami (debt portion) and Shalya Shah (For investments in ADR / GDR and other foreign securities).

Average AUM rises 4% in Q3FY15 q-o-q

Average assets under management (AAUM) of the mutual fund (MF) industry increased 3.67% (by Rs 38864.53 crore) to Rs 10.99 lakh crore during the quarter ended December 2014 as against Rs 10.597 lakh crore registered during the quarter ended September 2014, making it the fifth quarter of rise after fall in September 2013 quarter. The quarterly rise in AAUM is largely on account of gains in equity markets. Besides, retail participation in equity schemes has increased significantly during the recent months. The AAUM increased by 25% in December 2014 quarter compared with December 2013 quarter.

On quarterly basis, of the 41 mutual funds (data available), 29 fund houses registered rise in AAUM, while the rest resulted in fall during the December quarter. There were two mutual funds whose AAUM fell by over 10% and the names included —Peerless and Canara Robeco.

In the quarter ended December 2014 there were 09 fund houses which witnessed a rise in their average quarterly AUM in the range of 11% to 55%, while 20 AMCs saw a rise in the AUM in the range of 0.1%-10%.

Edelweiss posted more than 50% rise in AAUM, from Rs 379.70 crore to Rs 587.64 crore, the highest among the fund houses which witnessed rise in AAUM. It was followed by Motilal Oswal which posted 39.45% rise.

The top five fund houses — HDFC, Reliance, ICICI Prudential, Birla Sun Life and UTI gained an aggregate of Rs 6.09 lakh crore in their AAUM over the last quarter. Among the top 5 players, ICICI Prudential MF was the biggest gainer as its AAUM increased by 7.13% or by Rs 9099.60 crore to Rs 1.37 lakh crore over that in September 2014, retaining its second position. HDFC retained its top position and its AAUM increased by 6.35% to Rs 1.50 lakh crore. Birla Sun Life Mutual Fund gained 5.22% or Rs by 5352.34 crore during the quarter and its AAUM stood at Rs 1.08 lakh crore. Reliance MF grew 3.28%, to Rs 1.26 lakh crore.

UTI MF grew its assets by 4.97% but is still way behind from the Rs 1 lakh crore mark, at Rs 87390.13crore. Share of the top five mutual funds' assets was 55% in the December quarter.

Mutual funds continue buying

Net purchases of Rs 76.10 crore on 1 January 2015

Mutual funds bought shares worth a net Rs 76.10 crore on 1 January 2015, compared with their purchases of Rs 186 crore during the preceding trading session on 31 December 2014.

The net inflow of Rs 76.10 crore on 1 January 2015 was a result of gross purchases of Rs 400.20 crore and gross sales of Rs 324.10 crore. On that day, the S&P BSE Sensex rose 8.12 points or 0.03% to settle at 27,507.54, its highest closing level since 22 December 2014.

Mutual funds have bought shares worth Rs 76.10 crore in this month so far (till 1 January 2015). Mutual funds had bought shares worth Rs 7036.90 crore in December 2014.

UTI Fixed Term Income Fund-Series XVII-VI (366 Days) Announces Dividend

Record date for dividend is 08 January 2015

UTI Mutual Fund has announced 08 January 2015 as the record date for declaration of dividend under the dividend option of UTI Fixed Term Income Fund-Series XVII-VI (366 Days).

The amount of dividend on the face value of Rs 10 per unit will be 100% of distributable surplus as on the record date.

UTI Fixed Term Income Fund – Series XXI – II (1100 Days) Floats On

NFO period is from 02 January to 15 January 2015

UTI Mutual Fund has launched a new fund named as UTI Fixed Term Income Fund – Series XXI – II (1100 Days), a close ended income scheme. The duration of the scheme is 1100 days from the date of allotment. The New Fund Offer (NFO) price for the scheme is Rs 10 per unit. The new issue will be open for subscription from 02 January to 15 January 2015.

The investment objective of the scheme is to generate returns by investing in a portfolio of fixed income securities maturing on or before the date of maturity of the scheme.

The scheme offers growth option, quarterly dividend option with payout and reinvestment facility, flexi dividend option with payout and reinvestment facility, annual dividend option with payout and reinvestment facility and maturity dividend option with payout facility.

The scheme would allocate 80%-100% of assets in debt instruments with low to medium risk profile and invest upto 20% of assets would be allocated to money market instruments with low risk profile.

The minimum application amount is Rs 5000 and in multiples of Rs 10 under all the options.

The fund seeks to collect a minimum subscription (minimum target) amount of Rs 20 crore under the scheme during the NFO period.

Entry and exit load charge will be nil for the scheme.

Benchmark Index for the scheme is CRISIL Composite Bond Fund Index.

Manish Joshi is the fund manager for the scheme.

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.

In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.

Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.

Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.